Why is Shree Ganesh Bio falling/rising?

As of 13-Aug, Shree Ganesh Biotech India Ltd's stock is currently priced at Rs 0.79, reflecting a decrease of Rs 0.01 or 1.25%. The stock has underperformed today, with a performance that is 11.83% lower than its sector. Over the past month, the stock has declined by 5.95%, and year-to-date, it has seen a significant drop of 24.04%. The stock is close to its 52-week low, being only 3.75% away from Rs 0.77. The company is facing challenges, including operating losses and a weak ability to service its debt, as indicated by a poor EBIT to Interest ratio of 0.97. Additionally, the stock has generated a return of -34.17% over the past year, with profits falling by 48%, suggesting low profitability and a weak long-term fundamental strength.
In the broader market context, the Sensex has shown a slight decline of 0.01% over the past week, while the stock's performance has remained flat. The agriculture sector has gained by 12.61%, indicating that Shree Ganesh Biotech is lagging behind its peers. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 25.24% against the 5-day average, which may contribute to the stock's declining price. Overall, the combination of poor financial performance, weak market sentiment, and reduced trading activity suggests that the stock is facing significant headwinds, leading to its current downward movement.